Total Payments
$2,737
2024 Payments
$430.62
Companies
30
Transactions
144
Medicare Patients
1,393
Medicare Billing
$167,224
Payment Breakdown by Category
Food & Beverage$2,736 (100.0%)
Education$0.65 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,736 | 143 | 100.0% |
| Education | $0.65 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Indivior Inc. | $783.04 | 36 | $0 (2024) |
| ABBVIE INC. | $353.96 | 17 | $0 (2024) |
| Novo Nordisk Inc | $226.86 | 13 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $187.88 | 16 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $134.37 | 8 | $0 (2024) |
| Neos Therapeutics, LP | $133.32 | 4 | $0 (2018) |
| Lilly USA, LLC | $128.82 | 7 | $0 (2024) |
| Merck Sharp & Dohme LLC | $117.52 | 2 | $0 (2023) |
| ARBOR PHARMACEUTICALS, INC. | $70.14 | 5 | $0 (2018) |
| Antares Pharma, Inc. | $58.51 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $430.62 | 22 | Novo Nordisk Inc ($164.40) |
| 2023 | $442.62 | 24 | AbbVie Inc. ($77.58) |
| 2022 | $114.42 | 7 | Novo Nordisk Inc ($31.71) |
| 2021 | $208.66 | 15 | AbbVie Inc. ($66.43) |
| 2020 | $208.02 | 13 | Indivior Inc. ($67.86) |
| 2019 | $615.90 | 31 | Indivior Inc. ($434.20) |
| 2018 | $524.96 | 23 | Indivior Inc. ($241.15) |
| 2017 | $191.41 | 9 | AbbVie, Inc. ($135.33) |
All Payment Transactions
144 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Obesity | ||||||
| 09/23/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Respiratory | ||||||
| 07/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.23 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Diabetes | ||||||
| 04/26/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Obesity | ||||||
| 04/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Diabetes | ||||||
| 03/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Diabetes | ||||||
| 02/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: NEUROSCIENCE | ||||||
| 02/05/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: Opioid Use Disorder | ||||||
| 02/01/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: OUD | ||||||
| 12/11/2023 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Obesity | ||||||
| 10/26/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/12/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 356 | 1,007 | $84,799 | $47,493 |
| 2022 | 13 | 419 | 983 | $82,096 | $45,015 |
| 2021 | 12 | 389 | 929 | $80,539 | $47,708 |
| 2020 | 8 | 229 | 639 | $55,045 | $27,009 |
Total Patients
1,393
Total Services
3,558
Medicare Billing
$167,224
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 412 | $55,620 | $33,160 | 59.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 71 | $6,745 | $3,894 | 57.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 20 | 20 | $4,000 | $2,409 | 60.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 28 | 160 | $4,800 | $1,964 | 40.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 137 | $4,110 | $1,276 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $1,980 | $1,253 | 63.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $2,000 | $897.73 | 44.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 17 | 24 | $1,200 | $830.88 | 69.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 16 | 42 | $2,520 | $681.24 | 27.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 26 | 37 | $666.00 | $599.40 | 90.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 43 | 58 | $870.00 | $487.20 | 56.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 17 | 18 | $288.00 | $39.60 | 13.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 96 | 351 | $47,385 | $26,699 | 56.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 85 | $8,075 | $5,070 | 62.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $3,795 | $2,414 | 63.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 17 | 17 | $3,400 | $2,089 | 61.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 54 | $3,186 | $1,957 | 61.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 40 | 48 | $2,400 | $1,684 | 70.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $3,250 | $1,535 | 47.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 19 | 114 | $3,420 | $1,418 | 41.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 20 | 106 | $3,180 | $946.84 | 29.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 16 | 34 | $2,040 | $555.72 | 27.2% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 20 | 22 | $396.00 | $359.49 | 90.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 58 | 79 | $1,185 | $234.03 | 19.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 17 | 24 | $384.00 | $53.34 | 13.9% |
About Dr. Roger Brown, MD
Dr. Roger Brown, MD is a Family Medicine healthcare provider based in Martinez, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740204791.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Brown, MD has received a total of $2,737 in payments from pharmaceutical and medical device companies, with $430.62 received in 2024. These payments were reported across 144 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,736).
As a Medicare-enrolled provider, Brown has provided services to 1,393 Medicare beneficiaries, totaling 3,558 services with total Medicare billing of $167,224. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Martinez, GA
- Active Since 07/26/2006
- Last Updated 12/23/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1740204791
Products in Payments
- SUBLOCADE (Drug) $747.09
- VRAYLAR (Drug) $160.76
- Ozempic (Drug) $137.87
- Androgel (Drug) $135.33
- Adzenys XR-ODT (Drug) $133.32
- STEGLATRO (Drug) $117.52
- UBRELVY (Drug) $86.53
- VYVANSE (Drug) $75.99
- REXULTI (Drug) $67.96
- BREZTRI (Drug) $60.96
- XYOSTED (Drug) $57.50
- Otovel (Drug) $55.33
- Trintellix (Drug) $51.13
- BRIXADI (Drug) $50.80
- Rybelsus (Drug) $47.36
- AIRSUPRA (Drug) $42.74
- JARDIANCE (Drug) $40.71
- Evzio (Drug) $38.63
- MOUNJARO (Drug) $37.09
- ZEPBOUND (Drug) $36.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Martinez
Brent Porteous, D.o, D.O
Family Medicine — Payments: $54,795
Family Medicine $54,795
Melodie Armstrong, Md, MD
Family Medicine — Payments: $40,949
Family Medicine $40,949
Melissa Hubiak
Family Medicine — Payments: $4,853
Family Medicine $4,853
Dr. Richard Carpenter, D.o., Ph.d, D.O., PH.D
Family Medicine — Payments: $3,320
Family Medicine $3,320
Craig Desoer
Family Medicine — Payments: $2,927
Family Medicine $2,927
Benjamin Towe, Md, MD
Family Medicine — Payments: $2,022
Family Medicine $2,022